Impact of self-treated hypoglycaemia in type 2 diabetes: A multinational survey in patients and physicians

Current Medical Research and Opinion

Volumn 28, Issue 12, 2012, Pages 1947-1958

  Brod, Meryl ^a   Rana, Azhar ^b   Barnett, Anthony H ^c  

^a Brod Group   (United States)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adherence; Basal insulin; CHAID analysis; Hypoglycaemia; Insulin omission; Insulin therapy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN DERIVATIVE; ISOPHANE INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; DIABETIC PATIENT; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PHYSICIAN; PREVALENCE; RISK FACTOR; SELF CARE;

AGED; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SELF ADMINISTRATION;

EID: 84870421373     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.743457     Document Type: Article

References (23)

1. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hypergly-cemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009;32:193-203
2. Verges B, Brun JM, Tawil C, et al. Strategies for insulin initiation: insights from the French LIGHT observational study. Diabetes Metab Res Rev 2012;28:97-105
3. Unger J. Insulin initiation and intensification in patients with T2DM for the primary care physician. Diabetes Metab Syndr Obes 2011;4:253-61
4. Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010;33:733-5
5. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract 2008;62:860-8
6. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
7. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-9
8. Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ 2012;15:77-86
9. Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21:1477-83
10. Leiter LA, Yale J-F, Chiasson J-L, et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005;29:186-92
11. Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005;6:197-202
12. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958-71
13. Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007; CD005613
14. Valentine WJ, Jendle J, Saraheimo M, et al. Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabet Med 2012;29:303-12
15. Kass GV. An exploratory technique for investigating large quantities of categorical data. Appl Stat 1980;29:119-27
16. Marrett E, Radican L, Davies MJ, Zhang Q. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: a survey study. BMC Res Notes 2011;4:251
17. Miller CD, Phillips LS, Ziemer DC, et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653-9
18. Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2008;81:184-9
19. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
20. Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007;68:10-5
21. Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypo-glycaemia in Type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005;22:749-55
22. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-96
23. Allen C, LeCaire T, Palta M, et al. Risk factors for frequent and severe hypo-glycemia in type 1 diabetes. Diabetes Care 2001;24:1878-81